X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (66) 66
respiratory system (46) 46
pulmonary hypertension (45) 45
index medicus (43) 43
female (40) 40
male (38) 38
hypertension, pulmonary - drug therapy (30) 30
adult (27) 27
middle aged (27) 27
hypertension (25) 25
survival (21) 21
diagnosis (20) 20
treatment outcome (19) 19
hypertension, pulmonary - physiopathology (18) 18
therapy (18) 18
aged (17) 17
hemodynamics (16) 16
pulmonary arterial hypertension (16) 16
bosentan (14) 14
cardiac & cardiovascular systems (14) 14
hypertension, pulmonary - mortality (12) 12
pulmonary arteries (12) 12
endothelin receptor antagonists (11) 11
hypertension, pulmonary - diagnosis (11) 11
prognosis (11) 11
prospective studies (11) 11
arterial-hypertension (10) 10
abridged index medicus (9) 9
administration, inhalation (9) 9
antihypertensive agents - therapeutic use (9) 9
disease (9) 9
drug therapy (9) 9
internal medicine (9) 9
medicine & public health (9) 9
medicine, general & internal (9) 9
cardiology (8) 8
drug therapy, combination (8) 8
hypertension, pulmonary - etiology (8) 8
lung transplantation (8) 8
management (8) 8
patients (8) 8
pulmonary (8) 8
risk factors (8) 8
surgery (8) 8
care and treatment (7) 7
familial primary pulmonary hypertension (7) 7
hypertension, pulmonary (7) 7
hypertension, pulmonary - complications (7) 7
hypertension, pulmonary - therapy (7) 7
iloprost - administration & dosage (7) 7
prostacyclin (7) 7
severity of illness index (7) 7
sulfonamides - therapeutic use (7) 7
chronic thromboembolic pulmonary hypertension (6) 6
follow-up studies (6) 6
heart failure (6) 6
iloprost (6) 6
inhaled iloprost (6) 6
registries (6) 6
retrospective studies (6) 6
risk assessment (6) 6
transplantation (6) 6
vasodilator agents - therapeutic use (6) 6
übersicht | review article (6) 6
aerosols (5) 5
aged, 80 and over (5) 5
animals (5) 5
brain natriuretic peptide (5) 5
chronic disease (5) 5
clinical trials (5) 5
combination therapy (5) 5
double-blind (5) 5
exercise test (5) 5
heart (5) 5
hemodynamics - drug effects (5) 5
iloprost - therapeutic use (5) 5
infusion (5) 5
lung diseases (5) 5
mortality (5) 5
placebo-controlled trial (5) 5
pulmonary arterial-hypertension (5) 5
registry (5) 5
thromboembolism (5) 5
time factors (5) 5
transplantation of organs, tissues, etc (5) 5
usage (5) 5
vasodilator agents - administration & dosage (5) 5
antihypertensive agents - adverse effects (4) 4
calcium-channel blockers (4) 4
cardiovascular (4) 4
disease progression (4) 4
dosage and administration (4) 4
double-blind method (4) 4
emergency medicine (4) 4
expression (4) 4
guidelines (4) 4
health aspects (4) 4
hypertension, pulmonary - surgery (4) 4
intensive / critical care medicine (4) 4
kaplan-meier estimate (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 04/2019, Volume 38, Issue 4, pp. S96 - S96
Journal Article
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 02/2010, Volume 35, Issue 2, p. 461
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 04/2019, Volume 38, Issue 4, pp. S337 - S337
Journal Article
Medizinische Klinik - Intensivmedizin und Notfallmedizin, ISSN 2193-6218, 2/2017, Volume 112, Issue 1, pp. 42 - 46
Sepsis ist eine systemische Inflammationsreaktion des Organismus auf eine – häufig lokale – Infektion, für die es gegenwärtig keine zugelassene spezifische... 
Emergency Medicine | Cytokines | Plasmapherese | Intensive / Critical Care Medicine | Disseminierte intravasale Gerinnung | Internal Medicine | Disseminated intravascular coagulation | Systemische Endzündungsreaktion | Infektion | Plasmapheresis | Infection | Zytokine | Systemic inflammatory response syndrome | Medicine & Public Health
Journal Article